Analyst Ratings for Cerevel Therapeutics (CERE)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.8 / 10
Percentile Rank: 23%
Rating Score: 2.8 / 10
Percentile Rank: 23%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/22/2023 | Jefferies | Michael J. Yee | Downgrade | Hold (Buy) |
45.00 (40.00) |
41.32 (44.96) |
8.81% | Details |
| 12/18/2023 | Stifel | Paul Matteis | Downgrade | Hold (Buy) |
45.00 (N/A) |
41.22 (44.96) |
9.07% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
